Filter results
You can narrow down the results using the filters
Topics
Our work
Diseases
11623 results
-
National Framework for Communicable Disease Control
The framework was developed in partnership with states and territories. -
Primary Health Networks (PHN) and Aboriginal Community Controlled Health Organisations guiding principles
This document recognises the commitment by Primary Health Networks (PHNs) and Aboriginal Community Controlled Health Organisations (ACCHOs) to work together to improve access to health services and improve health outcomes for Aboriginal and Torres Strait Islander people. -
5:20
Sharon’s story – Don’t make it too late
Sharon, an Aboriginal health worker from Darwin, shares the story of how bowel cancer affected her family, after her father was diagnosed in 2014. Sharon encourages people to use the National Bowel Cancer Screening Program kit. -
Hepatitis A – Surveillance case definition
This document contains the surveillance case definition for hepatitis A, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
BreastScreen Australia – Response by Service/SCU (BSA005)
BreastScreen Australia services and State Coordination Units (SCUs) use this form to respond to issues identified in the Survey and Interim Survey Report and NAS Measures that are unmet, unable to be assessed or met with exception. It must be submitted as part of an application for accreditation. -
Advice to the Government on the Development of the Australian National Diabetes Strategy 2016–2020
The Australian Government based the Australian National Diabetes Strategy 2016–2020 on the framework provided in this report. -
Public Health and Chronic Disease Grant Program guidelines
The Public Health and Chronic Disease Grant program started on 1 July 2016. These guidelines outline the types of activities that this program funds, and how they are administered. -
Psychiatry – Australia’s Future Health Workforce report
This report outlines an analysis of the psychiatry workforce and the results of updated supply and demand projections, as well as considering capacity and distribution for vocational training into the future. It is part of our series on Australia’s Future Health Workforce. -
SSBA – Fact sheet 5 – List of SSBAs
This fact sheet contains the list of security sensitive biological agents (SSBAs) that we regulate in Australia. -
Pharmacy Trial Program principles
This document sets out the principles that proposals had to address when applying for Pharmacy Trial Program grants. -
SSBA – Guideline 7 – SSBAs in the natural environment
This guideline explains to entities, facilities and individuals their obligations for security sensitive biological agents (SSBAs) occurring in the natural environment. These SSBAs are not intended to be regulated under the SSBA Regulatory Scheme. -
Psittacosis – CDNA National Guidelines for Public Health Units
These guidelines for Public Health Units provide nationally consistent guidance on how to respond to psittacosis. They are part of a Series of National Guidelines (SoNGs) published by the Communicable Diseases Network Australia (CDNA). -
Healthy mouths, healthy lives – Australia’s National Oral Health Plan 2015–2024
The National Oral Health Plan 2015–2024 has 2 national goals. Firstly, to improve the oral health status of Australians by reducing the incidence, prevalence and effects of oral disease. And secondly to reduce inequalities in oral health status across the Australian population. -
Primary Health Networks (PHN) grant program guidelines
These guidelines outline how the Primary Health Networks (PHN) program and its funding arrangements work, as well as the responsibilities of funded PHNs. -
Medicare billing assurance toolkit - record keeping tips
These 10 simple tips will help you establish and maintain an effective administrative record keeping system. -
Medicare billing assurance template
This template is intended to assist practices develop a customised Medicare billing assurance manual. It contains examples of policy statements and operational guidance. -
Medicare billing assurance toolkit - post-participation questionnaire
Encourage health professionals in your practice to complete this questionnaire after undertaking a Medicare billing assurance review. You can use the responses to track perceptions and attitudes in your practice and identity areas to focus on. -
Medicare billing assurance toolkit - pre-participation questionnaire
Encourage health professionals in your practice to complete the following questionnaire before undertaking a Medicare billing assurance review of your practice. You can track perceptions and attitudes and identity trends to focus on. -
Medicare billing assurance charter
This Medicare billing assurance charter sets out the principles that support billing activities under Medicare. Your practice should consider adopting this Charter as part of its Medicare billing assurance approach. -
Medicare billing assurance manual template
This template helps practices develop a Medicare billing assurance manual. The manual can be customised to suit the particular requirements of each practice. It contains examples of policy statements and operational guidance which can create a Medicare billing assurance approach. -
Medicare billing assurance toolkit - step by step guide
The 5 Steps in the Toolkit make up a continuous improvement cycle for your practice’s Medicare billing assurance approach. -
Guideline for substantiating that a patient had a pre-existing condition at the time of the service
This guideline outlines what you can do to substantiate that an individual had a specified condition before the service is eligible. This relates to Medicare Benefits Schedule (MBS) items 11823, 18350 and 30511. -
Guideline for substantiating claims for diagnostic imaging and pathology services rendered to emergency department patients of public hospitals
This guideline outlines what you can do to substantiate diagnostic imaging and pathology services rendered to emergency department patients of public hospitals and claimed under Medicare. -
Guideline for substantiating proof of malignancy
This guideline outlines what you can do to substantiate histopathological proof of malignancy for Medicare Benefits Schedule (MBS) items 30196, 30197, 30202, 30203 and 30205. -
Guideline for substantiating that a patient attended a service
This guideline outlines what you can do to substantiate that a patient attended a service and relates to Medicare Benefits Schedule (MBS) items such as 23, 36, 104, 5020, 10960 and 8553 that require the patient to be present.